Raymond James Upgrades GoodRx Holdings to Outperform, Announces $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst John Ransom has upgraded GoodRx Holdings (NASDAQ:GDRX) from Market Perform to Outperform and set a price target of $10.
May 16, 2024 | 5:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Raymond James analyst John Ransom has upgraded GoodRx Holdings from Market Perform to Outperform and set a price target of $10.
The upgrade from Market Perform to Outperform by a reputable analyst and the announcement of a $10 price target is likely to positively impact GoodRx Holdings' stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100